DCF — VALLEYWISE HEALTH MEDICAL CENTER
Enterprise Value: $-450.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-450.5M
Enterprise Value
$-150.7M
PV of Cash Flows
$-299.8M
PV of Terminal Value
$-482.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $524.7M | $-23.6M | -4.0% | $-45.8M | $-41.7M |
| Year 2 | $540.4M | $-18.9M | -3.0% | $-41.8M | $-34.5M |
| Year 3 | $556.6M | $-13.9M | -2.0% | $-37.5M | $-28.2M |
| Year 4 | $573.3M | $-11.5M | -2.0% | $-35.7M | $-24.4M |
| Year 5 | $590.5M | $-10.3M | -2.0% | $-35.3M | $-21.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-450.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$509.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999999941107012
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5